Holen Sie sich die Stockscreener-App
5.97
5.01%
0.285
Finanzdaten der Kyverna Therapeutics Inc-Aktie (KYTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
4.38%
39.56
|
41.37 | 39.28 | 38.73 | 44.41 |
| Depreciation and Amortization |
50.00%
0.30
|
0.20 | - | 0.30 | 0.30 |
| Operating Income/Loss |
4.38%
-39.56
|
-41.37 | -39.28 | -38.73 | -44.41 |
| Nonoperating Income/Loss |
24.53%
1.237
|
1.639 | 1.478 | 1.94 | 2.329 |
| Net Income/Loss |
3.55%
-38.32
|
-39.73 | -37.80 | -36.79 | -42.08 |
| Basic Average Shares |
0.77%
60.90
|
60.43 | - | 43.42 | 43.23 |
| Diluted Average Shares |
0.77%
60.90
|
60.43 | - | 43.42 | 43.23 |
| Basic Earnings Per Share |
4.55%
-0.63
|
-0.66 | - | -0.85 | -0.97 |
| Diluted Earnings Per Share |
4.55%
-0.63
|
-0.66 | - | -0.85 | -0.97 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):